(NASDAQ: PRTC) Puretech Health's forecast annual revenue growth rate of 120.37% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.17%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Puretech Health's revenue in 2025 is $4,828,000.On average, 1 Wall Street analysts forecast PRTC's revenue for 2025 to be $6,823,507,392, with the lowest PRTC revenue forecast at $6,823,507,392, and the highest PRTC revenue forecast at $6,823,507,392.
In 2026, PRTC is forecast to generate $12,569,618,880 in revenue, with the lowest revenue forecast at $12,569,618,880 and the highest revenue forecast at $12,569,618,880.